Ingiliz, P <br/><br/>
Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  06 2018 
 - 1551-1552 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.14649  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Fatal Outcome<br/>Hepatitis B<br/>Hepatitis B e Antigens<br/>Hepatitis B, Chronic<br/>Humans<br/>Recurrence<br/>Seroconversion